U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma Biotech Investing
Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19 Biotech Investing
HempFusion's Wholly Owned Subsidiary Probulin Probiotics Launches Amazon Store and Expands Brick and Mortar Product Selection Biotech Investing
Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference Biotech Investing
Lexaria Bioscience Corp. Announces Closing of $11 Million Public Offering with Full Exercise of Underwriter Option to Purchase Additional Shares and Warrants Biotech Investing
